Colorectal adenocarcinoma in cirrhotic patients

Journal of the American College of Surgeons

Volumn 196, Issue 6, 2003, Pages 874-879

  Gervaz, Pascal ^a   Pak art, Rattaplee ^a   Nivatvongs, Santhat ^a   Wolff, Bruce G ^a   Larson, Dirk ^a   Ringel, Stacie ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BILIRUBIN;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; COLORECTAL ADENOCARCINOMA; COLORECTAL CARCINOMA; FEMALE; FOLLOW UP; HUMAN; LIVER CIRRHOSIS; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTHROMBIN TIME; RETROSPECTIVE STUDY; RISK FACTOR; SURGICAL MORTALITY; TUMOR CLASSIFICATION;

EID: 0037984913     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1072-7515(03)00117-0     Document Type: Article

References (28)

1. Taylor I. Colorectal cancer and the liver. Ann R Coll Surg Engl 1997;79:315-318.
2. Fong Y, Cohen AM, Fortner JG, et al. Liver resection for colorectal metastases. J Clin Oncol 1997;15:938-946.
3. Geoghegan JG, Scheele J. Treatment of colorectal liver metastases. Br J Surg 1999;86:158-169.
4. Paget S. Distribution of secondary growths in cancer of the breast. Lancet 1889;1:571-573.
5. Lieber MM. The rare occurrence of metastatic carcinoma in the cirrhotic liver. Am J Med Sci 1957;233:145-152.
6. Fisher ER, Hellstrom HR, Fisher B. Rarity of hepatic metastases in cirrhosis - a misconception. JAMA 1960;174:366-369.
7. Seymour K, Charnley RM. Evidence that metastasis is less common in cirrhotic than normal liver: a systematic review of post-mortem case-control studies. Br J Surg 1999;86:1237-1243.
8. Uetsuji S, Yamamura M, Yamamichi K, et al. Absence of colorectal cancer metastasis to the cirrhotic liver. Am J Surg 1992;164:176-177.
9. Utsunomiya T, Saitsu H, Saku M, et al. Rare occurrence of colorectal cancer metastasis in livers infected with hepatitis B or C virus. Am J Surg 1999;177:279-281.
10. Song E, Chen J, Ou Q, Su F. Rare occurrence of metastatic colorectal cancers in livers with replicative hepatitis B infection. Am J Surg 2001;181:529-533.
11. Pugh RNH, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-649.
12. Rikkers LF. Surgical complications of cirrhosis and portal hypertension. In: Sabiston DC Jr, ed. Textbook of surgery, 15th ed. Philadelphia: WB Saunders; 1997:1088-1103.
13. Erlinger S, Benhamou JP. Cirrhosis: clinical aspects. In: Bircher J, Benhamou JP, McIntyre N, et al, eds. Oxford textbook of clinical hepatology. 2nd ed. Oxford: Oxford University Press; 1999:629-641.
14. Zyser A, Plevak DJ, Wiesner RH, et al. Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery. Anesthesiology 1999;90:42-53.
15. Gopalswamy N, Mehta V, Barde CJ. Risks of intra-abdominal nonshunt surgery in cirrhotics. Dig Dis 1998;16:225-231.
16. Mansour A, Watson W, Shayani V, Pickleman J. Abdominal operations in patients with cirrhosis: still a major surgical challenge. Surgery 1997;122:730-736.
17. Wong R, Rappaport W, Witte C, et al. Risk of non-shunt abdominal operation in the patient with cirrhosis. J Am Coll Surg 1994;179:412-416.
18. Metcalf AM, Dozois RR, Wolff BG, Beart RW. The surgical risk of colectomy in patients with cirrhosis. Dis Colon Rectum 1987;30:529-531.
19. Rice HE, O'Keefe GE, Helton WS, Johansen K. Morbid prognostic features in patients with chronic liver failure undergoing nonhepatic surgery. Arch Surg 1997;132:880-885.
20. Azoulay D, Buabse F, Damiano I, et al. Neoadjuvant transjugular intrahepatic portosystemic shunt: a solution for extrahepatic abdominal operation in cirrhotic patients with severe portal hypertension. J Am Coll Surg 2001;193:46-51.
21. Fucini C, Wolff BG, Dozois RR. Bleeding from peristomal varices: perspectives on prevention and treatment. Dis Colon Rectum 1991;34:1073-1078.
22. Bilimoria MM, Lauwers GY, Doherty DA, et al. Underlying liver disease, not tumor factors, predicts long-term survival after resection of hepatocellular carcinoma. Arch Surg 2001;136:528-535.
23. Hayashi S, Masuda H, Shigematsu M. Liver metastasis is rare in colorectal cancer patients with fatty liver. Hepatogastroenterology 1997;44:1069-1075.
24. Utsunomiya T, Matsumata T. Metastatic carcinoma in the cirrhotic liver. Am J Surg 1993;166:776.
25. Galandiuk S, Wieand HS, Moertel CG, et al. Patterns of recurrence after curative resection of carcinoma of the colon and rectum. Surg Gyn Obst 1992;174:27-32.
26. Barsky SH, Gopalakrishna R. High metalloproteinase inhibitor content of human cirrhosis and its possible conference of metastasis resistance. J Natl Cancer Inst 1988;80:102-108.
27. Song E, Chen J, Ouyang, N, et al. Kupffer cells of cirrhotic rat livers sensitize colon cancer cells to Fas-mediated apoptosis. Br J Cancer 2001;84:1265-1271.
28. Gervaz P, Scholl B, Mainguene C, et al. Angiogenesis of liver metastasis: role of sinusoidal endothelial cells. Dis Colon Rectum 2000;43:980-986.